Oracle Investment Management as of June 30, 2024
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 22 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Genedx Holdings Corp Com Cl A (WGS) | 27.0 | $29M | 1.1M | 26.14 | |
| Biohaven (BHVN) | 22.7 | $24M | 701k | 34.71 | |
| Ardelyx (ARDX) | 10.3 | $11M | 1.5M | 7.41 | |
| Springworks Therapeutics (SWTX) | 8.2 | $8.8M | 233k | 37.67 | |
| Biohaven Call Call Option | 3.7 | $4.0M | 115k | 34.71 | |
| Quidel Corp (QDEL) | 3.7 | $3.9M | 118k | 33.22 | |
| Eyepoint Pharmaceuticals Call Call Option | 3.6 | $3.8M | 438k | 8.70 | |
| Forian Ord (FORA) | 3.4 | $3.6M | 1.4M | 2.65 | |
| BioCryst Pharmaceuticals (BCRX) | 3.1 | $3.3M | 536k | 6.18 | |
| Phathom Pharmaceuticals (PHAT) | 2.2 | $2.3M | 225k | 10.30 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.9 | $2.0M | 232k | 8.70 | |
| Ardelyx Call Call Option | 1.8 | $1.9M | 260k | 7.41 | |
| Myriad Genetics Call Call Option | 1.7 | $1.8M | 75k | 24.46 | |
| Palantir Technologies Call Call Option | 1.7 | $1.8M | 70k | 25.33 | |
| Cava Group Ord (CAVA) | 1.6 | $1.7M | 19k | 92.75 | |
| Myriad Genetics (MYGN) | 1.4 | $1.5M | 60k | 24.46 | |
| Springworks Therapeutics Call Call Option | 0.6 | $671k | 18k | 37.67 | |
| Pacific Biosciences of California (PACB) | 0.5 | $580k | 423k | 1.37 | |
| Biogen Idec (BIIB) | 0.5 | $559k | 2.4k | 231.82 | |
| Walgreen Boots Alliance | 0.3 | $333k | 28k | 12.10 | |
| Agenus Com New (AGEN) | 0.3 | $293k | 18k | 16.75 | |
| Biodesix (BDSX) | 0.0 | $44k | 29k | 1.53 |
